Concepedia
Statistics
Publications
11
Citations
558
H-Index
Active since
2020
Affiliations
Pfizer (United States)(Current)
Sorbonne Université
Erasmus MC
The Netherlands Cancer Institute
The University of Texas MD Anderson Cancer Center
Wenjing Yang is an author at Pfizer (United States) specializing in cancer immunotherapy, oncology, and tumor immunology.
Publications per year
2020–2025
Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity
Shih-Hsun Chen, Pawel K. Dominik, Jessica Stanfield et al. · Journal for ImmunoTherapy of Cancer · 2021 · 137 citations · Full text
Life Sciences, Immunology, Oncology +17
An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity
Yuanming Xu, Lucia Campos Carrascosa, Yik A. Yeung et al. · Cancer Immunology Research · 2021 · 98 citations · Full text
Baseline Frequency of Inflammatory Cxcl9-Expressing Tumor-Associated Macrophages Predicts Response to Avelumab Treatment
Yan Qu, Ji Wen, Graham D. Thomas et al. · Cell Reports · 2020 · 82 citations · Full text
Medicine, Immunology, Oncology +17
Yan Qu, Ji Wen, Graham D. Thomas et al. · Cell Reports · 2020 · 64 citations · Full text
First-in-human study of an OX40 (ivuxolimab) and 4-1BB (utomilumab) agonistic antibody combination in patients with advanced solid tumors
Omid Hamid, Alberto Chiappori, John A. Thompson et al. · Journal for ImmunoTherapy of Cancer · 2022 · 58 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 11